Cargando…
TSPO–PET imaging using [(18)F]PBR06 is a potential translatable biomarker for treatment response in Huntington’s disease: preclinical evidence with the p75(NTR) ligand LM11A-31
Huntington’s disease (HD) is an inherited neurodegenerative disorder that has no cure. HD therapeutic development would benefit from a non-invasive translatable biomarker to track disease progression and treatment response. A potential biomarker is using positron emission tomography (PET) imaging wi...
Autores principales: | Simmons, Danielle A, James, Michelle L, Belichenko, Nadia P, Semaan, Sarah, Condon, Christina, Kuan, Jason, Shuhendler, Adam J, Miao, Zheng, Chin, Frederick T, Longo, Frank M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077813/ https://www.ncbi.nlm.nih.gov/pubmed/29860333 http://dx.doi.org/10.1093/hmg/ddy202 |
Ejemplares similares
-
Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington’s Disease: Preclinical Evidence with the p75(NTR) Ligand LM11A-31
por: Simmons, Danielle A., et al.
Publicado: (2021) -
A small molecule p75(NTR) ligand normalizes signalling and reduces Huntington’s disease phenotypes in R6/2 and BACHD mice
por: Simmons, Danielle A., et al.
Publicado: (2016) -
A Small Molecule p75(NTR) Ligand, LM11A-31, Reverses Cholinergic Neurite Dystrophy in Alzheimer's Disease Mouse Models with Mid- to Late-Stage Disease Progression
por: Simmons, Danielle A., et al.
Publicado: (2014) -
p75(NTR) in Huntington's disease: beyond the basal ganglia
por: Brito, Verónica, et al.
Publicado: (2015) -
[(18)F]GE-180 PET Detects Reduced Microglia Activation After LM11A-31 Therapy in a Mouse Model of Alzheimer's Disease
por: James, Michelle L., et al.
Publicado: (2017)